About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

Luye Pharma Receives U.S. FDA Clearance to Initiate Clinical Trials for Its Novel Antidepressant LY03021

News

Shanghai, November 17, 2026 — Luye Pharma Group today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for LY03021, a next-generation central nervous system (CNS) drug ...

November 17,2026

Luye Pharma Announces Renewed Inclusion of Its Innovative Antidepressant Ruoxinlin® in China’s 2026 National Reimbursement Drug List

Shanghai, November 15, 2026 — Luye Pharma Group today announced that it has successfully renewed the coverage of Ruoxinlin® (toludesvenlafaxine hydrochloride sustained-release tablets), a Class 1 innovative drug in China for the ...

November 15,2026

Read More

Investors

Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company